Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonists
Scientists review the emerging trends in the use of antagonists to proteins PD-1/PD-L1 and gastrointestinal tumors.
Our Impact
Gastric Cancer Foundation improves the lives of people affected by gastric (stomach) cancer by supporting patient education initiatives and innovative research studies to improve treatments and ultimately, find a cure.
Support Research for a Cure
Every contribution to Gastric Cancer Foundation makes a difference. Honor a loved one, make a tribute to someone’s memory, honor a happy occasion by making a meaningful donation.
A Genetic Variant Located in miR-146b Promoter Region Is Associated with Prognosis of Gastric Cancer
A new study identifies a genetic variant associated with better survival outcomes in gastric cancer. This may be a useful... Read More
Prognostic indicators in stage IV surgically treated gastric cancer patients: A retrospective multi-institutional study
New research looks into short- and long-term outcomes of stage four surgically treated gastric cancer patients undergoing elective surgery.
Locally advanced gastro-oesophageal cancer: Recent therapeutic advances and research directions
Researchers in Cancer Treatment Reviews look into current treatment options for resectable gastric and gastro-oesophageal cancer.
Potentially curable gastric adenocarcinoma treated without surgery
A new study in the European Journal of Cancer finds combination chemoradiation therapy should be the preferred treatment option for... Read More
In breakthrough, Japanese researchers use AI to identify early stage stomach cancer with high accuracy
Two Japanese research institutes have been able to use artificial intelligence to accurately identify early stage gastric cancer in endoscopic... Read More
Timing of postoperative chemotherapy in patients undergoing perioperative chemotherapy and gastrectomy for gastric cancer
A study examines the timing of postoperative chemo on survival of gastric cancer patients who underwent perioperative chemotherapy and gastrectomy.
Houston Consensus Shrinks Gaps in H. Pylori Management
“There are clear gaps in testing, treatment, and follow-up for H pylori in North America, and we wanted to release... Read More
Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1
A new study shows possible clinical benefits of intraperitoneal paclitaxel for gastric cancer. Published in the Journal of Clinical Oncology,... Read More
Gastric cancer screening in high-risk groups cost-effective
A new modeling study in Gastroenterology shows gastric cancer screening in the US could be cost-effective in high-risk racial and... Read More
Endoscopic Surveillance Detects Early Gastric Cancer
Published in Gut, researchers in the Netherlands got some interesting insight in a study using endoscopy to catch gastric cancer... Read More
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
A new study published in The Lancet finds Keytruda, the PD-1 antibody pembrolizumab, may offer a better safety profile but... Read More
Breath Test Potential for Gastric Cancer Diagnosis
A study in JAMA Oncology suggests the potential of breath analysis as a noninvasive tool in diagnosing esophagogastric cancer. Read... Read More
Magnetically controlled capsule gastroscopy feasible for gastric cancer screening
Researchers in Shanghai found magnetically controlled capsule gastroscopy may be a safe, noninvasive, easy to perform and effective way to... Read More-
Phase 3 study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013)
Presented at the American Society of Clinical Oncology annual conference, researchers from Japan found doublet chemo with S-1 and cisplatin... Read More 
‘Prehab’ Boosts Fitness Before Upper GI Surgery
A small randomized trial found esophagogastric cancer patients who were prehabilitated before having surgery had significantly better functional capacity before... Read More-
Taiho Oncology and Servier to Present Data on LONSURF® (trifluridine and tipiracil) and Key Investigational Compound TAS-120 at ESMO 20th World Congress on Gastrointestinal Cancer 2018
Good results from the drug Lonsurf for treating metastatic gastric cancer in a phase 3 trial are being presented this... Read More 
Daiichi Sankyo Presents Long-Term Phase 1 Results of Antibody Drug Conjugate DS-8201 in Patients with HER2-Expressing Breast, Gastric and Other Solid Cancers at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
New research presented at the American Society of Clinical Oncology annual conference this month shares the comprehensive research program is... Read More
Outlooks on Epstein-Barr virus associated gastric cancer
New research finds Epstein-Barr virus associated gastric cancer (EBVaGC) associated gastric cancer, which comprises approximately 10% of gastric cancer, is a... Read More
Checkpoint inhibitors for the treatment of metastatic gastric cancers
Researchers evaluate early-phase and late-phase trials of immunotherapy in advanced gastric cancer. Read the full article in Cancer Treatment Reviews, Evolution... Read More
Monthly Newsletter
We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.